Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma

Cisplatin is the standard chemotherapeutic drug used for the treatment of esophageal squamous cell carcinoma (ESCC). Acquired cisplatin resistance is the primary obstacle to prolonging patient survival time. Here, the therapeutic effects of mitochondrial calcium uniporter (MCU) inhibition on tumor g...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yu, Wang, Xiaofei, Lai, Yafang, Huang, Ying, Yin, Hua, Meng, Xiangkun, Liu, Hao, Hou, Ruirui, Lin, Wan, Zhang, Xiaoxu, Zhang, Xu, Chai, Bei Cho, Zhang, Feixiong, Guo, Le, Yang, Shaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552700/
https://www.ncbi.nlm.nih.gov/pubmed/37264968
http://dx.doi.org/10.3892/ijo.2023.5530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552700/
https://www.ncbi.nlm.nih.gov/pubmed/37264968
http://dx.doi.org/10.3892/ijo.2023.5530

Ejemplares similares